SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy
Inflazyme Pharmaceuticals (T.IZP)
An SI Board Since June 1996
Posts SubjectMarks Bans Symbol
1501 24 0 IZP
Emcee:  Sean Janzen Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
676 Here's the agenda for the Arthritis conference November 17/18 in New OrleanSean Janzen-10/16/1997
675 Insider buying in ICOS: October 13, 1997 Sean Janzen-10/14/1997
674 To all: I and several thousand other people were down at the Seattle Money ShowGarth Richmond-10/7/1997
673 Good to hear from you again. IZP is not alone in seeking small molecules tSean Janzen-10/7/1997
672 There are already a lot of drugs available that block NF-KB (steroids) The onlySteven Busse-10/6/1997
671 Sean, Great find. I want to bring up the possibility that Canadian stocks mayHarold Lehman-10/5/1997
670 Frank, I will email you in the near future. Researchers find protein that proSean Janzen-10/2/1997
669 Sean, I can't tell you how nice it is to hear from you again. I'm stillstock talk-10/1/1997
668 The following comes from an article titled "Biotechs Need Results". Sean Janzen-10/1/1997
667 They're trying to get the paper published in the Journal of Respiratory andRob-9/30/1997
666 TSE is like your NYSE .The VSE is more junior, almost like your over- the- counSAM-DAN-9/30/1997
665 VSE is viewed in Canada as a junior market with a concentration of small resourDavid Culver-9/30/1997
664 SAM-DAN, I am not familiar with the canadian markets. What is the difference bHippieslayer-9/30/1997
663 >>Andy, I think that the off-label promotion allowed in the FDA reform biAndrew H-9/30/1997
662 Re your request for any abstracts-the only thing I could find was a review artiSAM-DAN-9/30/1997
661 Due to higher price requirements of NASDAQ we will probably see a listing on thSAM-DAN-9/30/1997
660 thanks seanHippieslayer-9/30/1997
659 Thanks, Sean, I am printing that out to put in my files> Aside from my Robert C. Petersen-9/30/1997
658 This web site covers the new listing requirements for the Nasdaq National MarkeSean Janzen-9/30/1997
657 Inflazyme will be presenting, Bispan: A Novel Anti-Inflammatory, at IBC's sSean Janzen-9/30/1997
656 What IZP really needs is major coverage. It has to be listed on Nasdaq. It has Hippieslayer-9/30/1997
655 Andy, I think that the off-label promotion allowed in the FDA reform bills willHenry Niman-9/30/1997
654 I think this stock will do well, also. Just hate to see folks on the thread getAndrew H-9/29/1997
653 I think your estimate of 5 years is way out of sinc. If Apanol shows no toxisiSAM-DAN-9/29/1997
652 I,for one, would like to see at least a three week Congressional hearing of theRobert C. Petersen-9/29/1997
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News